Cullinan Oncology Inc. (CGEM)
NASDAQ: CGEM
· Real-Time Price · USD
7.67
0.09 (1.19%)
At close: Aug 15, 2025, 3:59 PM
7.66
-0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT
Cullinan Oncology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.94M | 18.94M | 18.94M | 18.94M |
Cost of Revenue | 306K | 306K | 306K | 306K | 310K | 314K | 310K | 292K | 221K | 140K | 68K | 21K | 25K | 25K | 25K | 13K | n/a | n/a |
Gross Profit | -306K | -306K | -306K | -306K | -310K | -314K | -310K | -292K | -221K | -140K | -68K | -37.87M | -37.87M | -37.89M | -18.94M | 18.92M | 18.93M | 18.94M |
Operating Income | -234.7M | -208.93M | -196.92M | -187.36M | -183.74M | -171.32M | -191.09M | -178.21M | -162.74M | 114.55M | 144.65M | 142.91M | 154.3M | -101.98M | -67.95M | -62.78M | -55.9M | -53.42M |
Interest Income | 28.4M | 30.55M | 29.66M | 28.07M | 25.56M | 22.81M | 21.63M | 19.07M | 15.55M | 10.92M | 6.61M | 3.38M | 1.15M | 625K | 477K | 419K | 486K | 559K |
Pretax Income | -206.65M | -178.62M | -167.46M | -159.61M | -158.24M | -148.42M | -169.22M | -158.48M | -146.71M | 125.64M | 151.32M | 146.06M | 155.21M | -101.36M | -67.48M | -62.38M | -55.44M | -52.88M |
Net Income | -206.76M | -178.74M | -167.38M | -143.54M | -142.16M | -132.35M | -153.16M | -156.14M | -141.76M | 65.35M | 111.21M | 105.48M | 112.94M | -77.6M | -65.57M | -61.4M | -53.91M | -46.9M |
Selling & General & Admin | 56.21M | 55.13M | 53.86M | 49.87M | 47.5M | 44.02M | 42.42M | 43.14M | 42.25M | 42.73M | 40.19M | 42.37M | 37.98M | 32.11M | 29.15M | 28.22M | 24.11M | 20.91M |
Research & Development | 178.49M | 153.72M | 142.9M | 137.26M | 135.57M | 126.71M | 148.16M | 134.63M | 120.49M | 119.51M | 91.95M | 91.5M | 84.5M | 69.87M | 57.75M | 53.5M | 50.73M | 51.45M |
Other Expenses | -77K | -77K | -77K | n/a | 440K | 509K | 616K | 914K | 474K | 164K | 57K | -237K | -239K | -6K | -8K | -12K | -10K | -1K |
Operating Expenses | 234.62M | 208.77M | 196.69M | 187.13M | 183.51M | 171.17M | 191.01M | 178.21M | 162.74M | 162.24M | 132.14M | 133.88M | 122.48M | 101.98M | 86.9M | 81.72M | 74.85M | 72.36M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -77K | -153K | -230K | -230K | -153K | -77K | n/a | n/a | n/a | n/a | 600K | 600K | 600K | 600K | 600K | 600K | 600K |
Cost & Expenses | 234.7M | 208.93M | 196.92M | 187.36M | 183.74M | 171.32M | 191.09M | 178.21M | 162.74M | 162.24M | 132.14M | 133.88M | 122.48M | 101.98M | 86.9M | 81.72M | 74.85M | 72.36M |
Income Tax Expense | 117K | 117K | -75K | -14.31M | -14.31M | -14.31M | -14.3M | -2.04M | -4.56M | 61.51M | 42.12M | 44.2M | 46.73M | -19.34M | 223K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 59.02M | 58.91M | 58.58M | 58.34M | 55.05M | 43.01M | 42.79M | 42.73M | 39.95M | 40.68M | 45.75M | 45.61M | 44.87M | 44.43M | 43.52M | 43.44M | 43.3M | 41.98M |
Shares Outstanding (Diluted) | 59.02M | 58.91M | 58.58M | 58.34M | 55.05M | 43.01M | 42.79M | 42.73M | 39.95M | 40.68M | 45.75M | 45.61M | 46.38M | 44.43M | 43.64M | 43.44M | 43.3M | 41.98M |
EPS (Basic) | -3.52 | -3.09 | -3.13 | -2.88 | -3.1 | -3.15 | -3.71 | -3.74 | -3.36 | 1.35 | 2.50 | 2.35 | 2.49 | -1.77 | -1.5 | -1.44 | -1.3 | -1.39 |
EPS (Diluted) | -3.52 | -3.09 | -3.13 | -2.88 | -3.1 | -3.15 | -3.71 | -3.74 | -3.36 | 1.22 | 2.37 | 2.22 | 2.36 | -1.77 | -1.5 | -1.44 | -1.3 | -1.39 |
EBITDA | -234.47M | -208.62M | -196.61M | -187.05M | -182.99M | -170.57M | -190.34M | -177.48M | -162.51M | -160.38M | -130.34M | -132.13M | -120.73M | -101.93M | -67.9M | -62.72M | -55.85M | -53.11M |
EBIT | -221.44M | -201.41M | -189.4M | -187.36M | -183.3M | -170.88M | -190.65M | -179.77M | -164.74M | -162.54M | -132.44M | -132.18M | -120.78M | -101.98M | -67.95M | -62.71M | -55.84M | -53.11M |
Depreciation & Amortization | 306K | 306K | 306K | 306K | 310K | 314K | 310K | 292K | 221K | 152K | 93K | 46K | 50K | 51K | 53K | 56K | 58K | 61K |